Medytox Inc.
INTRODUCTION
PRODUCT LIST
Botulinum Toxin Type A Complex
Medytox Inc. is a biopharmaceutical company that focuses on developing
innovative biotech products necessary to diagnose and treat various diseases.
Botulinum Toxin Type A Biopharmaceutic
Botulinum Toxin Type A Biopharmaceutic, Neuronox, was approved and launched for the Korean market in 2006. It is widely used not only in the cosmetic field, including facial wrinkle reduction, but also in the therapeutic field, for people with cervical dystonia, cerebral palsy, etc. It is registered in 23 countries and in the process of registration in other 25 countries.